Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beam Therapeutics (BEAM) Preferred Dividend Payments (2019 - 2020)

Beam Therapeutics (BEAM) has disclosed Preferred Dividend Payments for 2 consecutive years, with $1.3 million as the latest value for Q1 2020.

  • On a quarterly basis, Preferred Dividend Payments fell 56.9% to $1.3 million in Q1 2020 year-over-year; TTM through Dec 2020 was $1.3 million, a 89.96% decrease, with the full-year FY2020 number at $1.3 million, down 89.96% from a year prior.
  • Preferred Dividend Payments was $1.3 million for Q1 2020 at Beam Therapeutics, down from $3.3 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $3.3 million in Q4 2019 to a low of $1.3 million in Q1 2020.